Innovative microfluidic chip uses only standard lab microscope to spot nano-biomolecules without any fluorescent labels
A novel invention by a team of researchers from the National University of Singapore (NUS) holds promise for a faster and cheaper way to diagnose diseases with high accuracy. Professor Zhang Yong from the Department of Biomedical Engineering at the NUS Faculty of Engineering and his team have developed a tiny microfluidic chip that could effectively detect minute amounts of biomolecules without the need for complex lab equipment.
Diseases diagnostics involves detection and quantification of nano-sized bio-particles such as DNA, proteins, viruses, and exosomes (extracellular vesicles). Typically, detection of biomolecules such as proteins are performed using colorimetric assays or fluorescent labelling with a secondary antibody for detection, and requires complex optical detection equipment such as fluorescent microscopy or spectrophotometry.
One alternative to reduce cost and complexity of disease detection is the adoption of label-free techniques, which are gaining traction in recent times. However, this approach requires precision engineering of nano-features (in a detection chip), complex optical setups, novel nano-probes (such as graphene oxide, carbon nanotubes, and gold nanorods) or additional amplification steps such as aggregation of nanoparticles to achieve sensitive detection of biomarkers.
“Our invention is an example of disruptive diagnostics. This tiny biochip can sensitively detect proteins and nano-sized polymer vesicles with a concentration as low as 10ng/mL (150 pM) and 3.75?g/mL respectively. It also has a very small footprint, weighing only 500 mg and is 6mm³ in size. Detection can be performed using standard laboratory microscopes, making this approach highly attractive for use in point-of-care diagnostics,” explained Prof Zhang.
His team, comprising Dr Kerwin Kwek Zeming and two NUS PhD students Mr Thoriq Salafi and Ms Swati Shikha, published their findings in scientific journal Nature Communications on 28 March 2018.
Novel approach for disease diagnosis
This novel fluorescent label-free approach uses the lateral shifts in the position of the microbead substrate in pillar arrays, for quantifying the biomolecules, based on the change in surface forces and size, without the need of any external equipment. Due to the usage of lateral displacement, the nano-biomolecules can be detected in real-time and the detection is significantly faster in comparison to fluorescent label based detection.
“These techniques can also be extended to many other types of nano-biomolecules, including nucleic acid and virus detection. To complement this chip technology, we are also developing a portable smartphone-based accessory and microfluidic pump to make the whole detection platform portable for outside laboratory disease diagnostics. We hope to further develop this technology for commercialisation,” said Prof Zhang.
The Latest on: Disease detection
via Google News
The Latest on: Disease detection
- Seeing and Measuring Hepatobiliary Disease Using Artificial Intelligence, Presented by Perspectum at RSNA 2019on November 14, 2019 at 4:21 pm
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191114005604/en/ Perspectum’s co-founder, Professor Sir Michael Brady, will show how ...
- Preventing Chronic Disease in Employees With Early Detectionon November 14, 2019 at 3:03 pm
Author Maren S. Fragala, PhD, CSCS.D, talks about how employer-sponsored health screenings can help identifiy previously undiagnosed disease, enabling early detection and treatment, and help keep ...
- Revised criteria lead to more accurate screening for eye disease in premature infantson November 14, 2019 at 8:07 am
while raising disease detection up to 100 percent. If implemented, this screening approach could considerably reduce both unnecessary health care costs and physically stressful retinal examinations ...
- Tennessee lung cancer cases, survival rates among the worst, but experts say more early detection will helpon November 13, 2019 at 1:39 pm
Tennessee ranks 47th in the nation (out of 51) for new lung cancer cases at a rate of 75.5 people out of 100,000 people. * Lung cancer screening is the key to early detection, when the disease is most ...
- Retinal imaging shows promise in early detection of Alzheimer'son November 13, 2019 at 9:16 am
Share on Pinterest Examining how the retina disperses light can provide insight into Alzheimer's disease. Scientists from the University of Minnesota in ... The researchers investigated retinal ...
- Misinformation widespread about chronic wasting disease in deer managementon November 12, 2019 at 9:08 am
Subsequent discoveries of CWD led to the creation of 3 more DMAs: DMA 2, following the detection of the disease in multiple free-ranging deer in Bedford, Blair, Cambria and Fulton counties in 2012, ...
- Breathing more easily: The key to saving lives from lung cancer is early detectionon November 12, 2019 at 1:53 am
The key to reducing lung cancer deaths is catching the disease early. But we’re not doing that ... This month, the Center for Early Detection, a new cancer philanthropy, is partnering with physicians ...
- Retinal imaging technology for early detection of Alzheimer's diseaseon November 12, 2019 at 1:35 am
In a recently published study in the ACS Chemical Neuroscience journal, University of Minnesota Professors Robert Vince and Swati More researched a promising retinal biomarker using a hyperspectral ...
- Multi-Center Clinical Study Demonstrates HeartTrends® Improves Early Detection for Heart Disease in Healthy Individualson November 11, 2019 at 4:14 pm
... Lev-El Diagnostics Ltd. Lev El Diagnostics of Heart Diseases Ltd. (Lev-El), is a privately held biomedical company specializing in non-invasive cardiovascular disease detection based on patented, ...
via Bing News